Tweaking the immune system: Gene therapy-assisted autologous haematopoietic stem cell transplantation as a treatment for autoimmune disease
- 31 December 2007
- journal article
- research article
- Published by Taylor & Francis in Autoimmunity
- Vol. 41 (8) , 679-685
- https://doi.org/10.1080/08916930802197123
Abstract
Autoimmune diseases represent a major challenge for medical research. The aberrant self-recognition by the immune system leads to a range of pathologies for which cures have not been forthcoming. Treatments are commonly non-specific and often lead to unwanted side-effects. A number of strategies are currently being explored to tackle autoimmunity; aimed at eliminating existing pathogenic clones and the induction of immune tolerance through resetting or regulating the immune system. Autologous haematopoietic stem cell transplantation (HSCT) is one such strategy and is being trailed in a number of autoimmune diseases. However, a common feature of this strategy is disease relapse and may indicate incomplete tolerance mechanisms. It is well known that bone marrow derived cells have a major influence on immune tolerance. It is also well documented that ectopic expression of antigens within the immune system can promote robust tolerance. This review considers these observations in the context of promoting a strategy involving genetic manipulation of haematopoietic stem cells together with HSCT to induce immune tolerance and tackle autoimmunity.Keywords
This publication has 55 references indexed in Scilit:
- Modulation of Aire regulates the expression of tissue-restricted antigensMolecular Immunology, 2008
- High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot studyBlood, 2007
- Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppressionThe Journal of Experimental Medicine, 2007
- Cell therapy for autoimmune diseasesArthritis Research & Therapy, 2007
- Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD miceThe Journal of Gene Medicine, 2006
- Central tolerance: good but imperfectImmunological Reviews, 2006
- Bone marrow transplantation combined with gene therapy to induce antigen-specific tolerance and ameliorate EAEMolecular Therapy, 2006
- Microchimerism maintains deletion of the donor cell-specific CD8+ T cell repertoireJournal of Clinical Investigation, 2005
- Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetesNature Immunology, 2004
- A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined ImmunodeficiencyNew England Journal of Medicine, 2003